The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nonerosive Reflux Disease Treatment Market Research Report 2025
Synopsis
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD).
The global Nonerosive Reflux Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nonerosive Reflux Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonerosive Reflux Disease Treatment.
Report Scope
The Nonerosive Reflux Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nonerosive Reflux Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonerosive Reflux Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Eisai
GlaxoSmithKline
Takeda Pharmaceutical
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
SRS Pharmaceuticals
SFJ Pharmaceuticals Group
Segment by Type
Proton pump inhibitors
H2 Receptor Antagonists
Antacids
Others
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonerosive Reflux Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD).
The global Nonerosive Reflux Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nonerosive Reflux Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonerosive Reflux Disease Treatment.
Report Scope
The Nonerosive Reflux Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nonerosive Reflux Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonerosive Reflux Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Eisai
GlaxoSmithKline
Takeda Pharmaceutical
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
SRS Pharmaceuticals
SFJ Pharmaceuticals Group
Segment by Type
Proton pump inhibitors
H2 Receptor Antagonists
Antacids
Others
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonerosive Reflux Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proton pump inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Antacids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nonerosive Reflux Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nonerosive Reflux Disease Treatment Market Perspective (2019-2030)
2.2 Nonerosive Reflux Disease Treatment Growth Trends by Region
2.2.1 Global Nonerosive Reflux Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nonerosive Reflux Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nonerosive Reflux Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nonerosive Reflux Disease Treatment Market Dynamics
2.3.1 Nonerosive Reflux Disease Treatment Industry Trends
2.3.2 Nonerosive Reflux Disease Treatment Market Drivers
2.3.3 Nonerosive Reflux Disease Treatment Market Challenges
2.3.4 Nonerosive Reflux Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nonerosive Reflux Disease Treatment Players by Revenue
3.1.1 Global Top Nonerosive Reflux Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Nonerosive Reflux Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nonerosive Reflux Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nonerosive Reflux Disease Treatment Revenue
3.4 Global Nonerosive Reflux Disease Treatment Market Concentration Ratio
3.4.1 Global Nonerosive Reflux Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonerosive Reflux Disease Treatment Revenue in 2023
3.5 Nonerosive Reflux Disease Treatment Key Players Head office and Area Served
3.6 Key Players Nonerosive Reflux Disease Treatment Product Solution and Service
3.7 Date of Enter into Nonerosive Reflux Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nonerosive Reflux Disease Treatment Breakdown Data by Type
4.1 Global Nonerosive Reflux Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Nonerosive Reflux Disease Treatment Breakdown Data by Application
5.1 Global Nonerosive Reflux Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nonerosive Reflux Disease Treatment Market Size (2019-2030)
6.2 North America Nonerosive Reflux Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024)
6.4 North America Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nonerosive Reflux Disease Treatment Market Size (2019-2030)
7.2 Europe Nonerosive Reflux Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Nonerosive Reflux Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nonerosive Reflux Disease Treatment Market Size (2019-2030)
9.2 Latin America Nonerosive Reflux Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nonerosive Reflux Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Nonerosive Reflux Disease Treatment Introduction
11.2.4 Eisai Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Detail
11.4.2 Takeda Pharmaceutical Business Overview
11.4.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Introduction
11.4.4 Takeda Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.4.5 Takeda Pharmaceutical Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Detail
11.6.2 Daewoong Pharmaceutical Business Overview
11.6.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Introduction
11.6.4 Daewoong Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Detail
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.7.5 Ironwood Pharmaceuticals Recent Development
11.8 SRS Pharmaceuticals
11.8.1 SRS Pharmaceuticals Company Detail
11.8.2 SRS Pharmaceuticals Business Overview
11.8.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Introduction
11.8.4 SRS Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.8.5 SRS Pharmaceuticals Recent Development
11.9 SFJ Pharmaceuticals Group
11.9.1 SFJ Pharmaceuticals Group Company Detail
11.9.2 SFJ Pharmaceuticals Group Business Overview
11.9.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Introduction
11.9.4 SFJ Pharmaceuticals Group Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024)
11.9.5 SFJ Pharmaceuticals Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Proton pump inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Antacids
Table 5. Key Players of Others
Table 6. Global Nonerosive Reflux Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Nonerosive Reflux Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Nonerosive Reflux Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Nonerosive Reflux Disease Treatment Market Share by Region (2019-2024)
Table 10. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Nonerosive Reflux Disease Treatment Market Share by Region (2025-2030)
Table 12. Nonerosive Reflux Disease Treatment Market Trends
Table 13. Nonerosive Reflux Disease Treatment Market Drivers
Table 14. Nonerosive Reflux Disease Treatment Market Challenges
Table 15. Nonerosive Reflux Disease Treatment Market Restraints
Table 16. Global Nonerosive Reflux Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Nonerosive Reflux Disease Treatment Market Share by Players (2019-2024)
Table 18. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2023)
Table 19. Ranking of Global Top Nonerosive Reflux Disease Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Nonerosive Reflux Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nonerosive Reflux Disease Treatment Product Solution and Service
Table 23. Date of Enter into Nonerosive Reflux Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nonerosive Reflux Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Nonerosive Reflux Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Nonerosive Reflux Disease Treatment Product
Table 51. AstraZeneca Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. Eisai Company Detail
Table 54. Eisai Business Overview
Table 55. Eisai Nonerosive Reflux Disease Treatment Product
Table 56. Eisai Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 57. Eisai Recent Development
Table 58. GlaxoSmithKline Company Detail
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product
Table 61. GlaxoSmithKline Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 62. GlaxoSmithKline Recent Development
Table 63. Takeda Pharmaceutical Company Detail
Table 64. Takeda Pharmaceutical Business Overview
Table 65. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 66. Takeda Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 67. Takeda Pharmaceutical Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Nonerosive Reflux Disease Treatment Product
Table 71. Johnson & Johnson Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Daewoong Pharmaceutical Company Detail
Table 74. Daewoong Pharmaceutical Business Overview
Table 75. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 76. Daewoong Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 77. Daewoong Pharmaceutical Recent Development
Table 78. Ironwood Pharmaceuticals Company Detail
Table 79. Ironwood Pharmaceuticals Business Overview
Table 80. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product
Table 81. Ironwood Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 82. Ironwood Pharmaceuticals Recent Development
Table 83. SRS Pharmaceuticals Company Detail
Table 84. SRS Pharmaceuticals Business Overview
Table 85. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product
Table 86. SRS Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 87. SRS Pharmaceuticals Recent Development
Table 88. SFJ Pharmaceuticals Group Company Detail
Table 89. SFJ Pharmaceuticals Group Business Overview
Table 90. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product
Table 91. SFJ Pharmaceuticals Group Revenue in Nonerosive Reflux Disease Treatment Business (2019-2024) & (US$ Million)
Table 92. SFJ Pharmaceuticals Group Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonerosive Reflux Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nonerosive Reflux Disease Treatment Market Share by Type: 2023 VS 2030
Figure 3. Proton pump inhibitors Features
Figure 4. H2 Receptor Antagonists Features
Figure 5. Antacids Features
Figure 6. Others Features
Figure 7. Global Nonerosive Reflux Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Nonerosive Reflux Disease Treatment Market Share by Application: 2023 VS 2030
Figure 9. Retail Pharmacies Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Nonerosive Reflux Disease Treatment Report Years Considered
Figure 13. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Nonerosive Reflux Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Nonerosive Reflux Disease Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Nonerosive Reflux Disease Treatment Market Share by Players in 2023
Figure 17. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Nonerosive Reflux Disease Treatment Revenue in 2023
Figure 19. North America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Nonerosive Reflux Disease Treatment Market Share by Country (2019-2030)
Figure 21. United States Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2019-2030)
Figure 25. Germany Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Region (2019-2030)
Figure 33. China Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nonerosive Reflux Disease Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 48. Eisai Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 52. Daewoong Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 53. Ironwood Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 54. SRS Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 55. SFJ Pharmaceuticals Group Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
